2022 the Japanese Society of Medical Oncology Annual Meeting

Session information

Oral Session

[O18] Oral Session 18 Gastrointestinal Cancer 3(Lower GI Tract-Colorectal Cancer 2)
【E】

Sat. Feb 19, 2022 10:10 AM - 11:40 AM Room 12 (Prince Hall 2, B2F, The Prince Kyoto Takaragaike)

Chair:Eiji Oki(Department of Surgery and Science, Kyushu University),Kei Muro(Department of Clinical Oncology, Aichi Cancer Center Hospital)
Discussant:Hiroya Taniguchi(Department of Clinical Oncology, Aichi Cancer Center Hospital)

Masataka Ikeda1, Hiroyuki Uetake2, Taishi Hata3, Takayuki Yoshino4, Mari Oba5 (1.Division of Lower Gastrointestinal Surgery, Department of Gastroenterological Surgery, Hyogo College of Medicine, 2.Department of Clinical Research, National Hospital Organization Disaster Medical Center, 3.Department of Surgery, Kansai Rosai Hospital, 4.Department of Gastrointestinal Oncology, National Cancer Center Hospital East, 5.Department of Clinical Epidemiology, Translational Medical Center, National Center of Neurology and Psychiatry)

Jun Watanabe1, Hiromichi Shirasu2, Masakazu Ikenaga3, Shingo Noura4, Tatsuro Yamaguchi5, Manabu Shiozawa6, Yoshinori Kagawa7, Masahiro Goto8, Makoto Yamada9, Alexey Aleshin10, Hiroki Yukami11, Saori Mishima11, Koji Ando12, Atsushi Hamabe13, Masaaki Miyo14, Hiromichi Ebi15, Daisuke Kotani11, Yoshiaki Nakamura11, Hiroya Taniguchi16, Takayuki Yoshino11 (1.Department of Surgery, Gastroenterological Center, Yokohama City University Medical Center, 2.Division of Gastrointestinal Oncology, Shizuoka Cancer Center, 3.Department of Gastroenterological Surgery, Higashiosaka City Medical Center, 4.Department of Surgery, Toyonaka Municipal Hospital, 5.Department of Surgery, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital,, 6.Department of Gastrointestinal Surgery, Kanagawa Cancer Center, 7.Department of Gastroenterological Surgery, Osaka General Medical Center, 8.Internal Medicine II, Osaka Medical and Pharmaceutical University Hospital, 9.Department of Surgery, Gifu Municipal Hospital, 10.Natera, Inc., San Carlos, CA, USA, 11.Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, 12.Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, 13.Department of Surgery, Surgical Oncology and Science, Sapporo Medical University, 14.Department of Surgery, National Hospital Organization Osaka National Hospital, 15.Division of Molecular Therapeutics, Aichi Cancer Center Research Institute, 16.Department of Clinical Oncology, Aichi Cancer Center Hospital)

Kentaro Yamazaki1, Satoshi Yuki2, Hiroya Taniguchi3, Hideaki Bando4, Yu Sunakawa5, Manabu Shiozawa6, Hisateru Yasui7, Naoki Takahashi9, Hironaga Satake9, Nobuhisa Matsuhashi10, Akiyoshi Kanazawa11, Yosuke Horita12, Masahiro Goto13, Naohiro Okano14, Kaname Yamashita15, Akihito Tsuji16, Hiromichi Ebi17, Yukiko Abe18, Shogo Nomura19, Takayuki Yoshino4 (1.Division of Gastrointestinal Oncology, Shizuoka Cancer Center, 2.Department of Gastroenterology and Hepatology, Hokkaido University Hospital, 3.Department of Clinical Oncology, Aichi Cancer Center Hospital, 4.Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, 5.Department of Clinical Oncology, St. Marianna University School of Medicine, 6.Department of Gastrointestinal Surgery, Kanagawa Cancer Center, 7.Department of Medical Oncology, Kobe City Medical Center General Hospital, 8.Department of Gastroenterology, Saitama Cancer Center, 9.Cancer Treatment Center, Kansai Medical University Hospital, 10.Department of Gastroenterological Surgery, Gifu University Hospital, 11.Department of Surgery, Shimane Prefectural Central Hospital, 12.Department of Gastroenterological Oncology, Saitama Medical University International Medical Center, 13.Cancer Chemotherapy Center, Osaka Medical College Hospital, 14.Department of Medical Oncology, Kyorin University Faculty of Medicine, 15.Division of Medical Oncology Cancer Research Institute, Kanazawa University, 16.Department of Clinical Oncology, Faculty of Medicine, Kagawa University, 17.Division of Molecular Therapeutics, Aichi Cancer Center Research Institute, 18.Board member, G&G Science Co., Ltd., 19.Clinical Research Support Office, National Cancer Center Hospital East)

Kensei Yamaguchi1, Salvatore Siena2, Kanwal Raghav3, Toshiki Masuishi4, Tomohiro Nishina5, Elena Elez6, Javier Rodriguez7, Ian Chau8, Maria Di Bartolomeo9, Hisato Kawakami10, Fumitaka Suto11, Kojiro Kobayashi11, Makito Koga12, Koichiro Inaki12, Yusuke Kuwahara12, Issey Takehara12, Axel Grothey13, Takayuki Yoshino14 (1.The Cancer Institute Hospital of JFCR, Tokyo, Japan, 2.Department of Oncology and Hemato-Oncology, Università degli Studi di Milano and Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy, 3.Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA, 4.Aichi Cancer Center Hospital, Aichi, Japan, 5.National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan, 6.Hospital Universitari Vall d’Hebron Institite of Oncology (VHIO), Barcelona, Spain, 7.Clinica Universidad de Navarra, Navarra, Spain, 8.Royal Marsden NHS Foundation Trust, Sutton, United Kingdom, 9.Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy, 10.Kindai University Hospital, Osaka, Japan, 11.Daiichi Sankyo, Inc., Basking Ridge, NJ, USA, 12.Daiichi Sankyo, Co., Ltd., Tokyo, Japan, 13.West Cancer Center, Germantown, TN, USA, 14.National Cancer Center Hospital East, Kashiwa, Japan)

Toshiki Masuishi1, Kotani Daisuke2, Takashima Atsuo3, Kato Takeshi4, Satoh Taroh5, Komatsu Yoshito6, Shiozawa Manabu7, Esaki Taito8, Izawa Naoki9, Takeuchi Shinji10, Bando Hideaki2, Iwasa Satoru3, Hasegawa Hiroko4, Yamaguchi Toshifumi5, Taniguchi Hiroya1, Yoshino Takayuki2 (1.Aichi Cancer Center Hospital, 2.National Cancer Center Hospital East, 3.National Cancer Center Hospital, 4.National Hospital Organization Osaka National Hospital, 5.Osaka University Hospital, 6.Hokkaido University Hospital, 7.Kanagawa Cancer Center, 8.National Hospital Organization Kyushu Cancer Center, 9.St. Marianna University School of Medicine Hospital, 10.Kanazawa University Hospital)

Toshifumi Yamaguchi1, Kotani Daisuke2, Takashima Atsuo3, Kato Takeshi4, Masuishi Toshiki5, Komatsu Yoshito6, Shiozawa Manabu7, Esaki Taito8, Izawa Naoki9, Takeuchi Shinji10, Bando Hideaki2, Iwasa Satoru3, Hasegawa Hiroko4, Satoh Taroh1, Taniguchi Hiroya5, Yoshino Takayuki2 (1.Osaka University Hospital, 2.National Cancer Center Hospital East, 3.National Cancer Center Hospital, 4.National Hospital Organization Osaka National Hospital, 5.Aichi Cancer Center Hospital, 6.Hokkaido University Hospital, 7.Kanagawa Cancer Center, 8.National Hospital Organization Kyushu Cancer Center, 9.St. Marianna University School of Medicine Hospital, 10.Kanazawa University Hospital)